Defibrillators in Nonischemic Cardiomyopathy Treatment Evaluation - DEFINITE


The goal of the trial was to evaluate whether standard medical therapy plus an implantable cardioverter defibrillator (ICD) will be associated with improvements in survival compared with standard medical therapy alone in patients with nonischemic dilated cardiomyopathy, ejection fraction (EF) ≤35%, and spontaneous premature ventricular complexes or nonsustained ventricular tachycardia.